These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7884021

  • 21. Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study.
    El-Mallakh RS, Salem MR, Chopra AS, Mickus GJ, Penagaluri P.
    Int Clin Psychopharmacol; 2009 May; 24(3):145-9. PubMed ID: 19367153
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study.
    Zhang ZJ, Kang WH, Tan QR, Li Q, Gao CG, Zhang FG, Wang HH, Ma XC, Chen C, Wang W, Guo L, Zhang YH, Yang XB, Yang GD.
    J Psychiatr Res; 2007 May; 41(3-4):360-9. PubMed ID: 16081106
    [Abstract] [Full Text] [Related]

  • 24. Carbamazepine in bipolar illness.
    Post RM, Uhde TW.
    Psychopharmacol Bull; 1985 May; 21(1):10-7. PubMed ID: 3885287
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Desipramine and cutaneous reactions in pediatric outpatients.
    Biederman J, Gonzalez E, Bronstein B, De Monaco H, Wright V.
    J Clin Psychiatry; 1988 May; 49(5):178-83. PubMed ID: 2966797
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Fixed pigmented erythema related to the oral administration of carbamazepine: report of one case].
    Alvarez VJ, Picón JE, Morales AR, Goncalves ET, Luna JR.
    Invest Clin; 2006 Mar; 47(1):65-9. PubMed ID: 16562645
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Extended-release carbamazepine (Equetro) for bipolar disorder.
    Med Lett Drugs Ther; 2005 Mar 28; 47(1205):27-8. PubMed ID: 15795684
    [Abstract] [Full Text] [Related]

  • 31. Treatment of bipolar depression with carbamazepine: results of an open study.
    Dilsaver SC, Swann SC, Chen YW, Shoaib A, Joe B, Krajewski KJ, Gruber N, Tsai Y.
    Biol Psychiatry; 1996 Nov 01; 40(9):935-7. PubMed ID: 8896785
    [No Abstract] [Full Text] [Related]

  • 32. [Carbamazepine in monotherapy in manic states; a series of 15 patients].
    Bourgeois M, Degeilh B, Etchépare JJ, Sudreau N, Géraud M.
    Ann Med Psychol (Paris); 1987 May 01; 145(5):439-46. PubMed ID: 3688699
    [No Abstract] [Full Text] [Related]

  • 33. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH, Dunner DL.
    Depress Anxiety; 2008 May 01; 25(2):91-7. PubMed ID: 17311265
    [Abstract] [Full Text] [Related]

  • 34. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE, McElroy SL.
    J Clin Psychiatry; 2002 May 01; 63 Suppl 10():13-7. PubMed ID: 12392348
    [Abstract] [Full Text] [Related]

  • 35. Psychosensory symptoms in bipolar disorder.
    Ali SO, Denicoff KD, Ketter TA, Smith-Jackson EE, Post RM.
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct 01; 10(4):223-31. PubMed ID: 9359118
    [Abstract] [Full Text] [Related]

  • 36. Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy.
    Ginsberg LD.
    Ann Clin Psychiatry; 2006 Oct 01; 18 Suppl 1():19-22. PubMed ID: 16754408
    [Abstract] [Full Text] [Related]

  • 37. Rational polypharmacy in the bipolar affective disorders.
    Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.
    Epilepsy Res Suppl; 1996 Oct 01; 11():153-80. PubMed ID: 9294735
    [Abstract] [Full Text] [Related]

  • 38. Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia.
    Kasper S.
    Depress Anxiety; 2004 Oct 01; 20(1):44-7. PubMed ID: 15368596
    [Abstract] [Full Text] [Related]

  • 39. Combined antidepressant treatment: a risk factor for switching in bipolar patients.
    Gabbay V, O'Dowd MA, Asnis GM.
    J Clin Psychiatry; 2002 Apr 01; 63(4):367; author reply 367-8. PubMed ID: 12000212
    [No Abstract] [Full Text] [Related]

  • 40. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug 01; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.